Evaluación de Tecnologías Sanitarias

Strategy to improve access to etiological treatment of Chagas disease at the first level of care in Argentina

K. Klein,M. S. Burrone,J. P. Alonso,L. R. Ares,S. G. Martí,A. Lavenia,E. Calderón,C. Spillmann and S. S. Estani. [Strategy to improve access to etiological treatment of Chagas disease at the first level of care in Argentina]. Rev Panam Salud Publica. 2017;41:10.26633/rpsp.2017.20.

Strategy to improve access to etiological treatment of Chagas disease at the first level of care in Argentina Ver más »

Risk factors for the development and recurrence of pressure ulcers in patients with spinal cord injury: A systematic review.

M. F. Di Prinzio,F. J. Argento,L. Barbalaco,M. E. Cazurro,A. Pereyra,C. Sanchez Correa,M. F. Schwab,N. Silva,D. Stawski,A. Vissani,A. Toth,E. Sánchez Hernández,M. Pedace and A. Annaratone. [Risk factors for the development and recurrence of pressure ulcers in patients with spinal cord injury: A systematic review.]. Rev Fac Cien Med Univ Nac Cordoba. 2019;76(4):10.31053/1853.0605.v76.n4.24906.

Risk factors for the development and recurrence of pressure ulcers in patients with spinal cord injury: A systematic review. Ver más »

Reflections on translational health research and the COVID-19 case in Argentina

J. M. Belizán,A. Bardach,G. Cormick,V. Irazola and R. Rey. [Reflections on translational health research and the COVID-19 case in Argentina]. Medicina (B Aires). 2020;80 Suppl 3.

Reflections on translational health research and the COVID-19 case in Argentina Ver más »

Mortality and recurrence of venous thromboembolic disease in adult patients: prospective cohort

M. L. Posadas-Martinez,V. L. Pagotto,M. F. Grande Ratti,V. Alfie,D. Andresik,F. Torres Gomez,D. H. Giunta,R. Luxardo,M. Scolnik and F. J. Vazquez. [Mortality and recurrence of venous thromboembolic disease in adult patients: prospective cohort]. Rev Fac Cien Med Univ Nac Cordoba. 2020;77(3):10.31053/1853.0605.v77.n3.27135.

Mortality and recurrence of venous thromboembolic disease in adult patients: prospective cohort Ver más »

Mecanismos de identificación y priorización de las tecnologías sanitarias a ser evaluadas por las Agencias de ETESA para decisiones de cobertura en Latino America

Pichon-Riviere A, Augustovski F, Garcia-Marti S, Alcaraz A, Alfie V, Sampietro-Colom L. [Mecanismos de identificación y priorización de las tecnologías sanitarias a ser evaluadas por las Agencias de ETESA para decisiones de cobertura en Latino America]. Int J Technol Assess Health Care. 2021 Aug 17;37(1):e81. Spanish. doi: 10.1017/S0266462321000519. PMID: 34399878.

Mecanismos de identificación y priorización de las tecnologías sanitarias a ser evaluadas por las Agencias de ETESA para decisiones de cobertura en Latino America Ver más »

Hypromellose derivatives for preventing SARS-CoV-2 infection: a systematic review

A. Hernández-Vásquez,D. Azañedo,R. Vargas-Fernández and D. Comandé. [Hypromellose derivatives for preventing SARS-CoV-2 infection: a systematic review]. Rev Peru Med Exp Salud Publica. 2021;38(3):10.17843/rpmesp.2021.383.9116.

Hypromellose derivatives for preventing SARS-CoV-2 infection: a systematic review Ver más »

High sensitivity C protein as an independent risk factor in people with and without history of cardiovascular disease

Brito V, Alcaraz A, Augustovski F, et al. [High sensitivity C protein as an independent risk factor in people with and without history of cardiovascular disease]. Archivos de cardiologia de Mexico. Apr-Jun 2015;85(2):124-135.

High sensitivity C protein as an independent risk factor in people with and without history of cardiovascular disease Ver más »